90 related articles for article (PubMed ID: 6859262)
1. Presence in normal human urine of a hypotensive and platelet-activating phospholipid.
Sánchez-Crespo M; Iñarrea P; Alvarez V; Alonso F; Egido J; Hernando L
Am J Physiol; 1983 Jun; 244(6):F706-11. PubMed ID: 6859262
[TBL] [Abstract][Full Text] [Related]
2. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
3. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Touqui L; Jacquemin C; Vargaftig BB
Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
[TBL] [Abstract][Full Text] [Related]
4. Partial characterization of the embryo-derived platelet-activating factor in mice.
O'Neill C
J Reprod Fertil; 1985 Nov; 75(2):375-80. PubMed ID: 4067921
[TBL] [Abstract][Full Text] [Related]
5. Functional and biochemical characterization of immunologically derived equine platelet-activating factor.
Wimberly HC; Slauson DO; Neilsen NR
Vet Pathol; 1985 Jul; 22(4):375-86. PubMed ID: 4035942
[TBL] [Abstract][Full Text] [Related]
6. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
7. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
8. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor and lyso-phosphatidylcholines from strawberry.
Calligerou M; Siafaka-Kapadai A; Galanopoulou D; Weintraub ST; Mavri-Vavayanni M
Phytochemistry; 1996 Jan; 41(1):89-92. PubMed ID: 8588879
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
Mencia-Huerta JM; Roubin R; Morgat JL; Benveniste J
J Immunol; 1982 Aug; 129(2):804-8. PubMed ID: 7086143
[TBL] [Abstract][Full Text] [Related]
11. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis of paf-acether by E. coli K12].
Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
[TBL] [Abstract][Full Text] [Related]
13. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
14. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
Camussi G; Tetta C; Coda R; Benveniste J
Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
[TBL] [Abstract][Full Text] [Related]
15. Rat renal papillary release of hypotensive substances in vitro.
Ma YH; Dunham EW
J Hypertens; 1991 Aug; 9(8):761-70. PubMed ID: 1655886
[TBL] [Abstract][Full Text] [Related]
16. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
Nunez D; Russo-Marie F; Benveniste J
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of platelet-activating factor in rabbit spermatozoa.
Kumar R; Harper MJ; Hanahan DJ
Arch Biochem Biophys; 1988 Jan; 260(1):497-502. PubMed ID: 3341753
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver.
Caramelo C; Fernández-Gallardo S; Santos JC; Iñarrea P; Sánchez-Crespo M; López-Novoa JM; Hernando L
Eur J Clin Invest; 1987 Feb; 17(1):7-11. PubMed ID: 3106053
[TBL] [Abstract][Full Text] [Related]
19. Simple and rapid measurement of platelet-activating factor (PAF) in whole blood.
Ou M; Kawasaki T; Sakon M; Kambayashi J; Siba E; Yokota M; Shinozaki K; Mori T
Biochem Int; 1991 Jul; 24(5):823-31. PubMed ID: 1776951
[TBL] [Abstract][Full Text] [Related]
20. Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses.
Blank ML; Cress EA; Lee TC; Malone B; Surles JR; Piantadosi C; Hajdu J; Snyder F
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):3-20. PubMed ID: 7146619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
